<?xml version="1.0" encoding="UTF-8"?>
<ArticalData xmlns="http://www.consortiumpublisher.com">
  <Header>
    <ArticleTitle>MEDICAL MANAGEMENT OF COVID-19 FROM BENCH TO BEDSIDE</ArticleTitle>
  </Header>
  <ArticleParameters>
    <ArticleReceivingDate>2020-06-20</ArticleReceivingDate>
    <ArticleRevisedDate>2020-07-28</ArticleRevisedDate>
    <ArticleAcceptanceDate>0020-08-20</ArticleAcceptanceDate>
    <ArticlePublishedOn>4/3/2025 10:44:53 AM</ArticlePublishedOn>
    <Journal>Journal of Applied Pharmacy</Journal>
    <Volume>12</Volume>
    <Year>2020</Year>
    <ArticleType>Conference abstract</ArticleType>
    <FirstPage>84</FirstPage>
    <LastPage>85</LastPage>
    <CollectionYear>2020</CollectionYear>
    <ArticleDoi>http://dx.doi.org/10.21065/19204159.12.84</ArticleDoi>
    <Language>English</Language>
  </ArticleParameters>
  <Authors>
    <ArticleAuthors>Bertha Serwa Ayi</ArticleAuthors>
  </Authors>
  <keywords />
  <Abstract>
    <ArticleAbstract>The SARS-CoV-2 virus is a novel coronavirus that has ravaged the world. Given that there
are no established treatments for coronaviruses, it presents a treatment dilemma for
scientists. This presentation explores the mechanisms that go into decision making on the
best treatment course for this illness with a special focus on the role of Hydroxychloroquine
and Zinc.</ArticleAbstract>
  </Abstract>
</ArticalData>